BeOne Medicines Ltd. (ONC)

Instructure Holdings Revenue

BeOne Medicines had revenue of $1.12B in the quarter ending March 31, 2025, with 48.64% growth. This brings the company's revenue in the last twelve months to $4.18B, up 51.16% year-over-year. In the year 2024, BeOne Medicines had annual revenue of $3.81B with 54.96% growth.

• Revenue (ttm): $4.18B
• Revenue Growth: +51.16%
• P/S Ratio: 7.59
• Revenue / Employee: $379,624
• Employees: 11,000
• Market Cap: 35.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.81B	1.35B	54.96%
Dec 31, 2023	2.46B	1.04B	73.65%
Dec 31, 2022	1.42B	239.64M	20.37%
Dec 31, 2021	1.18B	867.41M	280.83%
Dec 31, 2020	308.87M	-119.34M	-27.87%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.